NCT00685334View on ClinicalTrials.gov

Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Eating Disorders
Interventions
DRUG

Olanzapine

Participants will take olanzapine daily for 12 weeks.

DRUG

Aripiprazole

Participants will take aripiprazole daily for 12 weeks.

Trial Locations (2)

10032

New York State Psychiatric Institute, New York

M5G2C4

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00685334 - Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa | Biotech Hunter | Biotech Hunter